Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: Two-Year Real-World Study.

Autor:	Chou YB; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan., Chang HH; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan., Chiu HI; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan., Chou YJ; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan., Pu C; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Jazyk:	angličtina
Zdroj:	Ophthalmic epidemiology [Ophthalmic Epidemiol] 2024 Jul 31, pp. 1-9. Date of Electronic Publication: 2024 Jul 31.
DOI:	10.1080/09286586.2024.2370260
Abstrakt:	Purpose: To explore potential risk factors for the development of neovascular glaucoma (NVG) in central retinal vein occlusion (CRVO) over a two-year intensive follow-up period. Methods: This study reviewed 1545 patients with CRVO between 2005 and 2019 at Taipei Veterans General Hospital. Inclusion was restricted to (1) patients with acute CRVO within 3 months; (2) patients with ocular neovascularization at initial presentation (3) patients had not received any treatment at the time of CRVO; (4) at least bimonthly follow-up schedule over the course of 2 years. The included patients were screened for potential risk factors for developing NVG and assessed with Kaplan-Meier survival analysis and Cox regression model. Results: Among the included 123 patients, the cumulative probability of developing NVG was 26.8% (33/123 cases) in overall follow-up period. The mean interval between the onset of CRVO and NVG was 507 days. Neither macular edema nor central macular thickness at baseline was correlated with the development of NVG ( p =.104 and .25, respectively). Patients with diabetes mellitus (DM), older age, and poor vision independently played significant risk factors for developing NVG after controlling other covariates. ( p =.034, .001, and .013, respectively). Conclusions: Patients presenting with CRVO who have comorbidities such as DM, older age, and worse VA warrant closer attention and intensive follow-up for the development of NVG. Additionally, the statistical analysis indicated that the presence of macular edema, increased central macular thickness, CV events, history of glaucoma, and early PRP within 3 months had no significant impact on the likelihood of developing NVG.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu